de State Street Quest Diagnostics DGX Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 1169 M | Comprar |
5,516,643
+135,822
| +3% | +USD 26.7 M | 0.03% | 382 |
|
|
2026
Q1 | USD 1055 M | Vender |
5,380,821
-1,726
| -0% | -USD 335 k | 0.04% | 376 |
|
|
2025
Q4 | USD 934 M | Comprar |
5,382,547
+158,617
| +3% | +USD 28.9 M | 0.03% | 408 |
|
|
2025
Q3 | USD 996 M | Comprar |
5,223,930
+38,931
| +0.8% | +USD 6.91 M | 0.03% | 402 |
|
|
2025
Q2 | USD 931 M | Comprar |
5,184,999
+8,140
| +0.2% | +USD 1.41 M | 0.03% | 401 |
|
|
2025
Q1 | USD 876 M | Vender |
5,176,859
-44,617
| -0.9% | -USD 7.33 M | 0.04% | 400 |
|
|
2024
Q4 | USD 788 M | Vender |
5,221,476
-41,755
| -0.8% | -USD 6.49 M | 0.03% | 435 |
|
|
2024
Q3 | USD 817 M | Comprar |
5,263,231
+70,578
| +1% | +USD 10.5 M | 0.03% | 424 |
|
|
2024
Q2 | USD 711 M | Vender |
5,192,653
-6,541
| -0.1% | -USD 896 k | 0.03% | 437 |
|
|
2024
Q1 | USD 692 M | Vender |
5,199,194
-130,918
| -2% | -USD 17 M | 0.03% | 455 |
|
|
2023
Q4 | USD 735 M | Vender |
5,330,112
-11,293
| -0.2% | -USD 1.48 M | 0.04% | 421 |
|
|
2023
Q3 | USD 651 M | Vender |
5,341,405
-190,365
| -3% | -USD 25.4 M | 0.04% | 420 |
|
|
2023
Q2 | USD 778 M | Vender |
5,531,770
-144,188
| -3% | -USD 19.9 M | 0.04% | 386 |
|
|
2023
Q1 | USD 803 M | Vender |
5,675,958
-182,651
| -3% | -USD 26.1 M | 0.05% | 378 |
|
|
2022
Q4 | USD 917 M | Vender |
5,858,609
-123,888
| -2% | -USD 17.8 M | 0.05% | 343 |
|
|
2022
Q3 | USD 734 M | Vender |
5,982,497
-64,296
| -1% | -USD 8.47 M | 0.05% | 378 |
|
|
2022
Q2 | USD 804 M | Vender |
6,046,793
-83,802
| -1% | -USD 11.4 M | 0.05% | 357 |
|
|
2022
Q1 | USD 839 M | Vender |
6,130,595
-115,124
| -2% | -USD 16 M | 0.04% | 394 |
|
|
2021
Q4 | USD 1081 M | Comprar |
6,245,719
+144,251
| +2% | +USD 21.9 M | 0.05% | 350 |
|
|
2021
Q3 | USD 887 M | Vender |
6,101,468
-107,834
| -2% | -USD 15.8 M | 0.05% | 366 |
|
|
2021
Q2 | USD 819 M | Comprar |
6,209,302
+145,692
| +2% | +USD 19.1 M | 0.04% | 394 |
|
|
2021
Q1 | USD 778 M | Vender |
6,063,610
-292,382
| -5% | -USD 36 M | 0.04% | 379 |
|
|
2020
Q4 | USD 757 M | Vender |
6,355,992
-323,354
| -5% | -USD 39.4 M | 0.05% | 370 |
|
|
2020
Q3 | USD 765 M | Comprar |
6,679,346
+6,458
| +0.1% | +USD 763 k | 0.05% | 329 |
|
|
2020
Q2 | USD 760 M | Vender |
6,672,888
-145,910
| -2% | -USD 15.5 M | 0.06% | 317 |
|
|
2020
Q1 | USD 548 M | Comprar |
6,818,798
+179,263
| +3% | +USD 18.6 M | 0.05% | 341 |
|
|
2019
Q4 | USD 709 M | Comprar |
6,639,535
+297,204
| +5% | +USD 31 M | 0.05% | 360 |
|
|
2019
Q3 | USD 679 M | Comprar |
6,342,331
+48,167
| +0.8% | +USD 4.94 M | 0.05% | 357 |
|
|
2019
Q2 | USD 641 M | Vender |
6,294,164
-91,456
| -1% | -USD 8.79 M | 0.05% | 368 |
|
|
2019
Q1 | USD 574 M | Comprar |
6,385,620
+58,649
| +0.9% | +USD 5.08 M | 0.04% | 390 |
|
|
2018
Q4 | USD 527 M | Comprar |
6,326,971
+8,126
| +0.1% | +USD 762 k | 0.05% | 368 |
|
|
2018
Q3 | USD 682 M | Comprar |
6,318,845
+148,721
| +2% | +USD 16.3 M | 0.05% | 345 |
|
|
2018
Q2 | USD 678 M | Vender |
6,170,124
-167,259
| -3% | -USD 17.4 M | 0.06% | 327 |
|
|
2018
Q1 | USD 636 M | Vender |
6,337,383
-293,578
| -4% | -USD 30.1 M | 0.05% | 351 |
|
|
2017
Q4 | USD 653 M | Vender |
6,630,961
-109,414
| -2% | -USD 10.4 M | 0.05% | 352 |
|
|
2017
Q3 | USD 631 M | Vender |
6,740,375
-83,848
| -1% | -USD 8.9 M | 0.05% | 346 |
|
|
2017
Q2 | USD 759 M | Vender |
6,824,223
-94,677
| -1% | -USD 10 M | 0.07% | 295 |
|
|
2017
Q1 | USD 679 M | Comprar |
6,918,900
+180,690
| +3% | +USD 17.2 M | 0.06% | 321 |
|
|
2016
Q4 | USD 619 M | Comprar |
6,738,210
+462,214
| +7% | +USD 39.8 M | 0.06% | 330 |
|
|
2016
Q3 | USD 531 M | Comprar |
6,275,996
+194,702
| +3% | +USD 16.4 M | 0.05% | 353 |
|
|
2016
Q2 | USD 495 M | Vender |
6,081,294
-48,554
| -0.8% | -USD 3.7 M | 0.05% | 354 |
|
|
2016
Q1 | USD 438 M | Vender |
6,129,848
-33,973
| -0.6% | -USD 2.28 M | 0.05% | 395 |
|
|
2015
Q4 | USD 438 M | Comprar |
6,163,821
+5,878
| +0.1% | +USD 395 k | 0.05% | 381 |
|
|
2015
Q3 | USD 379 M | Vender |
6,157,943
-29,336
| -0.5% | -USD 2.05 M | 0.04% | 411 |
|
|
2015
Q2 | USD 449 M | Vender |
6,187,279
-277,871
| -4% | -USD 20.5 M | 0.05% | 375 |
|
|
2015
Q1 | USD 497 M | Vender |
6,465,150
-241,688
| -4% | -USD 17.3 M | 0.05% | 366 |
|
|
2014
Q4 | USD 450 M | Comprar |
6,706,838
+179,859
| +3% | +USD 11.3 M | 0.04% | 399 |
|
|
2014
Q3 | USD 396 M | Comprar |
6,526,979
+193,232
| +3% | +USD 11.9 M | 0.04% | 409 |
|
|
2014
Q2 | USD 372 M | Vender |
6,333,747
-34,405
| -0.5% | -USD 2.01 M | 0.04% | 426 |
|
|
2014
Q1 | USD 369 M | Vender |
6,368,152
-192,834
| -3% | -USD 10.3 M | 0.04% | 410 |
|
|
2013
Q4 | USD 351 M | Vender |
6,560,986
-81,635
| -1% | -USD 4.84 M | 0.04% | 429 |
|
|
2013
Q3 | USD 410 M | Vender |
6,642,621
-85,287
| -1% | -USD 5.1 M | 0.05% | 365 |
|
|
2013
Q2 | USD 408 M | Comprar |
+6,727,908
| Nuevas | +USD 401 M | 0.05% | 355 |
|
Otros fondos que tienen DGX en su cartera
Posición de State Street en DGX: resumen de T2 2026
State Street aumentó su participación en Quest Diagnostics (DGX) en 2.5% durante T2 2026, al comprar aproximadamente USD 26.7 M y elevar la posición a 5,516,643 acciones con un valor de USD 1169 M. La posición representa 0.03% de la cartera y ocupa el puesto #382.
State Street reportó por primera vez una posición en DGX en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 1,112 fondos que sigue Wall St. Rank mantienen una posición en DGX.
- Al cierre de T2 2026, State Street tenía 5,516,643 acciones de Quest Diagnostics con un valor de USD 1169 M.
- State Street compró 135,822 acciones de Quest Diagnostics en T2 2026, por un monto estimado de USD 26.7 M.
- Quest Diagnostics representó 0.03% de la cartera de State Street en T2 2026 y fue su posición número 382.
- State Street reportó por primera vez una posición en Quest Diagnostics en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 1,112 fondos que sigue Wall St. Rank tenían Quest Diagnostics en cartera.
Según el Informe 13F de State Street correspondiente a T2 2026, presentado el 7 ago 2026.